Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Prima Additive, a company specialising in metal Additive Manufacturing and advanced laser technologies, has officially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback